{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:01:14Z","timestamp":1792785674829,"version":"4.5.0"},"reference-count":48,"publisher":"IOP Publishing","issue":"20","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/iop-standard\/v1"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/iopscience.iop.org\/info\/page\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/questions\/alternative-author-rights-policies\/"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/questions\/alternative-author-rights-policies\/"}],"funder":[{"name":"NIH","award":["R01CA301448"],"award-info":[{"award-number":["R01CA301448"]}]},{"name":"IBA"},{"name":"Elekta","id":[{"id":"https:\/\/ror.org\/02j2cf778","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["iopscience.iop.org"],"crossmark-restriction":false},"short-container-title":["Phys. Med. Biol."],"published-print":{"date-parts":[[2026,10,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Objective.<\/jats:italic>\n                    Stereotactic body radiotherapy with a simultaneous integrated boost (SBRT-SIB) for locally advanced pancreatic cancer (LAPC) is constrained by the proximity of serial gastrointestinal organs at risk (OARs). Conventional intensity-modulated proton therapy (IMPT) relies on a limited number of fixed beam angles, which may restrict dose shaping around these critical structures. This study evaluated whether non-coplanar spot-scanning proton arc therapy (SPArc-4\n                    <jats:inline-formula>\n                      <jats:tex-math>\n                        \n                      <\/jats:tex-math>\n                      <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" overflow=\"scroll\">\n                        <mml:mrow>\n                          <mml:mi>\u03c0<\/mml:mi>\n                        <\/mml:mrow>\n                      <\/mml:math>\n                    <\/jats:inline-formula>\n                    ) could improve OAR sparing while preserving robust target coverage.\n                    <jats:italic>Approach.<\/jats:italic>\n                    10 patients with LAPC were retrospectively selected in this study. For each patient, SBRT-SIB plans were generated using conventional IMPT and SPArc-4\n                    <jats:inline-formula>\n                      <jats:tex-math>\n                        \n                      <\/jats:tex-math>\n                      <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" overflow=\"scroll\">\n                        <mml:mrow>\n                          <mml:mi>\u03c0<\/mml:mi>\n                        <\/mml:mrow>\n                      <\/mml:math>\n                    <\/jats:inline-formula>\n                    . Plan robustness was assessed across 21 uncertainty scenarios. Target coverage, conformity, OAR doses, estimated delivery time, and Lyman\u2013Kutcher\u2013Burman normal tissue complication probability for four gastrointestinal endpoints were compared using the Wilcoxon signed-rank test.\n                    <jats:italic>Main results.<\/jats:italic>\n                    SPArc-4\n                    <jats:inline-formula>\n                      <jats:tex-math>\n                        \n                      <\/jats:tex-math>\n                      <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" overflow=\"scroll\">\n                        <mml:mrow>\n                          <mml:mi>\u03c0<\/mml:mi>\n                        <\/mml:mrow>\n                      <\/mml:math>\n                    <\/jats:inline-formula>\n                    maintained target coverage comparable to IMPT, with similar clinical target volume (CTV) and boost-volume coverage, while CTV conformity improved with SPArc-4\n                    <jats:inline-formula>\n                      <jats:tex-math>\n                        \n                      <\/jats:tex-math>\n                      <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" overflow=\"scroll\">\n                        <mml:mrow>\n                          <mml:mi>\u03c0<\/mml:mi>\n                        <\/mml:mrow>\n                      <\/mml:math>\n                    <\/jats:inline-formula>\n                    (conformity index: 0.50 vs. 0.56;\n                    <jats:italic>p<\/jats:italic>\n                    = 0.02). SPArc-4\n                    <jats:inline-formula>\n                      <jats:tex-math>\n                        \n                      <\/jats:tex-math>\n                      <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" overflow=\"scroll\">\n                        <mml:mrow>\n                          <mml:mi>\u03c0<\/mml:mi>\n                        <\/mml:mrow>\n                      <\/mml:math>\n                    <\/jats:inline-formula>\n                    significantly reduced maximum dose (Gy(RBE)) to the stomach (30.01\u201324.53), duodenum (35.14\u201333.14), bowel (32.60\u201328.91), and spinal cord (15.38 to 5.58; all\n                    <jats:italic>p<\/jats:italic>\n                    <jats:inline-formula>\n                      <jats:tex-math>\n                        \n                      <\/jats:tex-math>\n                      <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" overflow=\"scroll\">\n                        <mml:mrow>\n                          <mml:mtext>\u2a7d<\/mml:mtext>\n                        <\/mml:mrow>\n                      <\/mml:math>\n                    <\/jats:inline-formula>\n                    0.01). Predicted toxicity decreased across all four gastrointestinal endpoints: gastric bleed risk decreased from 8.19% to 6.15%, grade\n                    <jats:inline-formula>\n                      <jats:tex-math>\n                        \n                      <\/jats:tex-math>\n                      <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" overflow=\"scroll\">\n                        <mml:mrow>\n                          <mml:mtext>\u2a7e<\/mml:mtext>\n                        <\/mml:mrow>\n                      <\/mml:math>\n                    <\/jats:inline-formula>\n                    3 gastrointestinal toxicity from 3.91% to 3.81%, ulceration\/perforation from 0.03% to 0.01%, and diarrhea from 24.14% to 22.34% (all\n                    <jats:inline-formula>\n                      <jats:tex-math>\n                        \n                      <\/jats:tex-math>\n                      <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" overflow=\"scroll\">\n                        <mml:mrow>\n                          <mml:mi>p<\/mml:mi>\n                          <mml:mrow>\n                            <mml:mtext>\u2a7d<\/mml:mtext>\n                          <\/mml:mrow>\n                          <mml:mn>0.005<\/mml:mn>\n                        <\/mml:mrow>\n                      <\/mml:math>\n                    <\/jats:inline-formula>\n                    ). All plans met robustness criteria. The main trade-off was delivery efficiency, with SPArc-4\n                    <jats:inline-formula>\n                      <jats:tex-math>\n                        \n                      <\/jats:tex-math>\n                      <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" overflow=\"scroll\">\n                        <mml:mrow>\n                          <mml:mi>\u03c0<\/mml:mi>\n                        <\/mml:mrow>\n                      <\/mml:math>\n                    <\/jats:inline-formula>\n                    requiring approximately 2\u20133 min longer delivery time than IMPT.\n                    <jats:italic>Significance.<\/jats:italic>\n                    SPArc-4\n                    <jats:inline-formula>\n                      <jats:tex-math>\n                        \n                      <\/jats:tex-math>\n                      <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" overflow=\"scroll\">\n                        <mml:mrow>\n                          <mml:mi>\u03c0<\/mml:mi>\n                        <\/mml:mrow>\n                      <\/mml:math>\n                    <\/jats:inline-formula>\n                    provides a promising proton planning strategy for pancreatic SBRT-SIB by preserving robust target coverage while improving gastrointestinal organ sparing and reducing predicted toxicity. These findings support further investigation of SPArc-4\n                    <jats:inline-formula>\n                      <jats:tex-math>\n                        \n                      <\/jats:tex-math>\n                      <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" overflow=\"scroll\">\n                        <mml:mrow>\n                          <mml:mi>\u03c0<\/mml:mi>\n                        <\/mml:mrow>\n                      <\/mml:math>\n                    <\/jats:inline-formula>\n                    for safer dose escalation in LAPC.\n                  <\/jats:p>","DOI":"10.1088\/1361-6560\/aeb05f","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:51:36Z","timestamp":1791240696000},"page":"205019","update-policy":"https:\/\/doi.org\/10.1088\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Introduce\n                    <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                      <mml:mrow>\n                        <mml:mn>4<\/mml:mn>\n                        <mml:mi>\u03c0<\/mml:mi>\n                      <\/mml:mrow>\n                    <\/mml:math>\n                    dynamic spot-scanning proton arc therapy (SPArc-4\n                    <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                      <mml:mrow>\n                        <mml:mi>\u03c0<\/mml:mi>\n                      <\/mml:mrow>\n                    <\/mml:math>\n                    ) for pancreatic cancer: a comparative planning study with IMPT"],"prefix":"10.1088","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4820-914X","authenticated-orcid":false,"given":"Peng","family":"Chen","sequence":"first","affiliation":[{"name":"Cleveland Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peilin","family":"Liu","sequence":"additional","affiliation":[{"name":"Corewell Health William Beaumont University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5175-630X","authenticated-orcid":true,"given":"Xiaoda","family":"Cong","sequence":"additional","affiliation":[{"name":"Corewell Health William Beaumont University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gao","sequence":"additional","affiliation":[{"name":"Peking University First Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8348-456X","authenticated-orcid":true,"given":"Xianshu","family":"Gao","sequence":"additional","affiliation":[{"name":"Peking University First Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanfeng","family":"Ding","sequence":"additional","affiliation":[{"name":"Corewell Health William Beaumont University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"266","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"pmbaeb05fbib1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.983984","type":"journal-article","article-title":"Stomach and duodenum dose-volume constraints for locally advanced pancreatic cancer patients treated in 15 fractions in combination with chemotherapy","volume":"12","author":"Broggi","year":"2023","journal-title":"Frontiers Oncol."},{"key":"pmbaeb05fbib2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.radonc.2020.07.052","type":"journal-article","article-title":"Estro acrop guidelines for target volume definition in pancreatic cancer","volume":"154","author":"Brunner","year":"2021","journal-title":"Radiother. Oncol."},{"key":"pmbaeb05fbib3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.radonc.2017.05.013","type":"journal-article","article-title":"An evaluation of motion mitigation techniques for pancreatic SBRT","volume":"124","author":"Campbell","year":"2017","journal-title":"Radiother. Oncol."},{"key":"pmbaeb05fbib4","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13014-020-01676-3","type":"journal-article","article-title":"Feasibility study: spot-scanning proton arc therapy (SPArc) for left-sided whole breast radiotherapy","volume":"15","author":"Chang","year":"2020","journal-title":"Radiat. Oncol."},{"key":"pmbaeb05fbib5","doi-asserted-by":"publisher","DOI":"10.1002\/mp.70639","type":"journal-article","article-title":"Develop a novel non-coplanar trajectory optimization algorithm for an efficient 4pi spot-scanning proton arc (sparc-4pi) treatment delivery","volume":"53","author":"Cong","year":"2026","journal-title":"Med. Phys."},{"key":"pmbaeb05fbib6","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/mp.16098","type":"journal-article","article-title":"Spot-scanning proton arc therapy reduces toxicity in oropharyngeal cancer patients","volume":"50","author":"de Jong","year":"2023","journal-title":"Med. Phys."},{"key":"pmbaeb05fbib7","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.ijrobp.2016.08.049","type":"journal-article","article-title":"Spot-scanning proton arc (sparc) therapy: the first robust and delivery-efficient spot-scanning proton arc therapy","volume":"96","author":"Ding","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"pmbaeb05fbib8","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ab1175","type":"journal-article","article-title":"Comparing the effectiveness and efficiency of various gating approaches for PBS proton therapy of pancreatic cancer using 4D-MRI datasets","volume":"64","author":"Dolde","year":"2019","journal-title":"Phys. Med. Biol."},{"key":"pmbaeb05fbib9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jrras.2025.101596","type":"journal-article","article-title":"The potential of 4 \u03c0 radiotherapy: a comprehensive sanra-compliant narrative review of advancements and challenges","volume":"18","author":"Donati","year":"2025","journal-title":"J. Radiat. Res. Appl. Sci."},{"key":"pmbaeb05fbib10","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.ijrobp.2012.09.028","type":"journal-article","article-title":"4 \u03c0 non-coplanar liver SBRT: a novel delivery technique","volume":"85","author":"Dong","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"pmbaeb05fbib11","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1186\/s12885-024-13094-9","type":"journal-article","article-title":"Effect of breathing phase number on the 4D robust optimization for pancreatic cancer intensity modulated proton therapy","volume":"24","author":"Fan","year":"2024","journal-title":"BMC Cancer"},{"key":"pmbaeb05fbib12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ijrobp.2005.09.028","type":"journal-article","article-title":"Conformity index: a review","volume":"64","author":"Feuvret","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"pmbaeb05fbib13","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1259\/0007-1285-62-740-679","type":"journal-article","article-title":"The linear-quadratic formula and progress in fractionated radiotherapy","volume":"62","author":"Fowler","year":"1989","journal-title":"Br. J. Radiol."},{"key":"pmbaeb05fbib14","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ijrobp.2013.01.024","type":"journal-article","article-title":"Motion interplay as a function of patient parameters and spot size in spot scanning proton therapy for lung cancer","volume":"86","author":"Grassberger","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"pmbaeb05fbib15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phro.2021.12.001","type":"journal-article","article-title":"Intrafraction pancreatic tumor motion patterns during ungated magnetic resonance guided radiotherapy with an abdominal corset","volume":"21","author":"Grimbergen","year":"2022","journal-title":"Phys. Imaging Radiat. Oncol."},{"key":"pmbaeb05fbib16","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/acdcdc","type":"journal-article","article-title":"4D dosimetric-blood flow model: impact of prolonged fraction delivery times of IMRT on the dose to the circulating lymphocytes","volume":"68","author":"Hammi","year":"2023","journal-title":"Phys. Med. Biol."},{"key":"pmbaeb05fbib17","doi-asserted-by":"publisher","DOI":"10.1016\/j.phro.2026.101070","type":"journal-article","article-title":"Impact of dynamic beam delivery of intensity-modulated radiation therapy and volumetric modulated arc therapy on circulating immune cell exposure in glioma","volume":"41","author":"Hammi","year":"2026","journal-title":"Phys. Imaging Radiat. Oncol."},{"key":"pmbaeb05fbib18","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.radonc.2017.04.024","type":"journal-article","article-title":"Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data","volume":"123","author":"Holyoake","year":"2017","journal-title":"Radiother. Oncol."},{"key":"pmbaeb05fbib19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.radonc.2020.11.007","type":"journal-article","article-title":"SPARC, a phase-i trial of pre-operative, margin intensified, stereotactic body radiation therapy for pancreatic cancer","volume":"155","author":"Holyoake","year":"2021","journal-title":"Radiother. Oncol."},{"key":"pmbaeb05fbib20","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/0284186X.2017.1293287","type":"journal-article","article-title":"A study of the beam-specific interplay effect in proton pencil beam scanning delivery in lung cancer","volume":"56","author":"Kang","year":"2017","journal-title":"Acta Oncol."},{"key":"pmbaeb05fbib21","doi-asserted-by":"publisher","first-page":"e495","DOI":"10.1016\/j.prro.2020.01.012","type":"journal-article","article-title":"Dose-escalated radiation therapy for pancreatic cancer: a simultaneous integrated boost approach","volume":"10","author":"Koay","year":"2020","journal-title":"Pract. Radiat. Oncol."},{"key":"pmbaeb05fbib22","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/0360-3016(89)90972-3","type":"journal-article","article-title":"Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method gerald","volume":"16","author":"Kutcher","year":"1989","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"pmbaeb05fbib23","doi-asserted-by":"publisher","DOI":"10.1118\/1.4773312","type":"journal-article","article-title":"Use of treatment log files in spot scanning proton therapy as part of patient-specific quality assurance","volume":"40","author":"Li","year":"2013","journal-title":"Med. Phys."},{"key":"pmbaeb05fbib24","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.radonc.2019.04.032","type":"journal-article","article-title":"The first prototype of spot-scanning proton arc treatment delivery","volume":"137","author":"Li","year":"2019","journal-title":"Radiother. Oncol."},{"key":"pmbaeb05fbib25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.698537","type":"journal-article","article-title":"Linear energy transfer incorporated spot-scanning proton arc therapy optimization: a feasibility study","volume":"11","author":"Li","year":"2021","journal-title":"Frontiers Oncol."},{"key":"pmbaeb05fbib26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13014-018-0981-6","type":"journal-article","article-title":"Improve dosimetric outcome in stage III non-small-cell lung cancer treatment using spot-scanning proton arc (SPArc) therapy","volume":"13","author":"Li","year":"2018","journal-title":"Radiat. Oncol."},{"key":"pmbaeb05fbib27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13014-020-1476-9","type":"journal-article","article-title":"Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study","volume":"15","author":"Liu","year":"2020","journal-title":"Radiat. Oncol."},{"key":"pmbaeb05fbib28","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/acfec5","type":"journal-article","article-title":"The first investigation of spot-scanning proton arc (sparc) delivery time and accuracy with different delivery tolerance window settings","volume":"68","author":"Liu","year":"2023","journal-title":"Phys. Med. Biol."},{"key":"pmbaeb05fbib29","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1002\/mp.16879","type":"journal-article","article-title":"Development of a standalone delivery sequence model for proton arc therapy","volume":"51","author":"Liu","year":"2024a","journal-title":"Med. Phys."},{"key":"pmbaeb05fbib30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmp.2024.104816","type":"journal-article","article-title":"Investigate potential clinical benefits and linear energy transfer sparing utilizing proton arc therapy for hepatocellular carcinoma","volume":"126","author":"Liu","year":"2024b","journal-title":"Phys. Medica"},{"key":"pmbaeb05fbib31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpt.2025.100749","type":"journal-article","article-title":"First clinical implementation of step-and-shoot proton arc therapy for head and neck cancer treatment","volume":"16","author":"Liu","year":"2025","journal-title":"Int. J. Part. Ther."},{"key":"pmbaeb05fbib32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.747532","type":"journal-article","article-title":"Investigate the dosimetric and potential clinical benefits utilizing stereotactic body radiation therapy with simultaneous integrated boost technique for locally advanced pancreatic cancer: a comparison between photon and proton beam therapy","volume":"11","author":"Liu","year":"2021","journal-title":"Frontiers Oncol."},{"key":"pmbaeb05fbib33","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ad5827","type":"journal-article","article-title":"The first investigation of the dosimetric perturbations from the spot position errors in spot-scanning arc therapy (sparc)","volume":"69","author":"Liu","year":"2024c","journal-title":"Phys. Med. Biol."},{"key":"pmbaeb05fbib34","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ae2aa5","type":"journal-article","article-title":"A novel and fast 3D dosimetry for patient-specific quality assurance in proton therapy","volume":"71","author":"Luo","year":"2025","journal-title":"Phys. Med. Biol."},{"key":"pmbaeb05fbib35","article-title":"Cancer stat facts: pancreatic cancer","author":"National Cancer Institute","year":"2026","type":"other"},{"key":"pmbaeb05fbib36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/rpd\/ncp005","type":"journal-article","article-title":"International commission on radiation units and measurements report 78: prescribing, recording and reporting proton-beam therapy","volume":"133","author":"Newhauser","year":"2009","journal-title":"Radiat. Prot. Dosim."},{"key":"pmbaeb05fbib37","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1016\/j.prro.2019.07.018","type":"journal-article","article-title":"Australasian gastrointestinal trials group (AGITG) and trans-tasman radiation oncology group (TROG) guidelines for pancreatic stereotactic body radiation therapy (SBRT)","volume":"10","author":"Oar","year":"2020","journal-title":"Pract. Radiat. Oncol."},{"key":"pmbaeb05fbib38","doi-asserted-by":"publisher","first-page":"R419","DOI":"10.1088\/0031-9155\/59\/22\/R419","type":"journal-article","article-title":"Relative biological effectiveness (rbe) values for proton beam therapy. variations as a function of biological endpoint, dose and linear energy transfer","volume":"59","author":"Paganetti","year":"2014","journal-title":"Phys. Med. Biol."},{"key":"pmbaeb05fbib39","doi-asserted-by":"publisher","first-page":"S217","DOI":"10.1016\/S0360-3016(03)01031-9","type":"journal-article","article-title":"Analysis of radiation-induced gastric and duodenal bleeds using the Lyman-Kutcher-Burman model","volume":"57","author":"Pan","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"pmbaeb05fbib40","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.3390\/cancers13061390","type":"journal-article","article-title":"Biophysical analysis of acute and late toxicity of radiotherapy in gastric marginal zone lymphoma\u2014impact of radiation dose and planning target volume","volume":"13","author":"Reinartz","year":"2021","journal-title":"Cancers"},{"key":"pmbaeb05fbib41","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70043","type":"journal-article","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J. Clin."},{"key":"pmbaeb05fbib42","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ad2718","type":"journal-article","article-title":"Impact of and interplay between proton arc therapy and range uncertainties in proton therapy for head-and-neck cancer","volume":"69","author":"Tattenberg","year":"2024","journal-title":"Phys. Med. Biol."},{"key":"pmbaeb05fbib43","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1002\/cncr.32756","type":"journal-article","article-title":"Conventionally fractionated radiation therapy versus stereotactic body radiation therapy for locally advanced pancreatic cancer (crisp): an international systematic review and meta-analysis","volume":"126","author":"Tchelebi","year":"2020","journal-title":"Cancer"},{"key":"pmbaeb05fbib44","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.ijrobp.2016.08.038","type":"journal-article","article-title":"Reoptimization of intensity modulated proton therapy plans based on linear energy transfer","volume":"96","author":"Unkelbach","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"pmbaeb05fbib45","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3390\/cancers11070976","type":"journal-article","article-title":"Locally advanced pancreatic cancer: work-up, staging and local intervention strategies","volume":"11","author":"(the Dutch Pancreatic Cancer Group and on Locally Advanced Pancreatic Cancer, I. C. G.)","year":"2019","journal-title":"Cancers"},{"key":"pmbaeb05fbib46","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.radonc.2016.12.030","type":"journal-article","article-title":"Dosimetric parameters correlate with duodenal histopathologic damage after stereotactic body radiotherapy for pancreatic cancer: secondary analysis of a prospective clinical trial","volume":"122","author":"Verma","year":"2017","journal-title":"Radiother. Oncol."},{"key":"pmbaeb05fbib47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.meddos.2014.09.001","type":"journal-article","article-title":"Dosimetric evaluation of simultaneous integrated boost during stereotactic body radiation therapy for pancreatic cancer","volume":"40","author":"Yang","year":"2015","journal-title":"Med. Dosim."},{"key":"pmbaeb05fbib48","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1002\/cncr.30706","type":"journal-article","article-title":"Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation","volume":"123","author":"Zhong","year":"2017","journal-title":"Cancer"}],"container-title":["Physics in Medicine &amp; Biology"],"original-title":[],"link":[{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/aeb05f","content-type":"text\/html","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/aeb05f\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/aeb05f","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/aeb05f\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/aeb05f\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/aeb05f\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/aeb05f\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"similarity-checking"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/aeb05f\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:31:28Z","timestamp":1792675888000},"score":1,"resource":{"primary":{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/aeb05f"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":48,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2026,10,22]]},"published-print":{"date-parts":[[2026,10,28]]}},"URL":"https:\/\/doi.org\/10.1088\/1361-6560\/aeb05f","relation":{},"ISSN":["0031-9155","1361-6560"],"issn-type":[{"value":"0031-9155","type":"print"},{"value":"1361-6560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"Introduce\n                      \n                        \n                          4\n                          \u03c0\n                        \n                      \n                      dynamic spot-scanning proton arc therapy (SPArc-4\n                      \n                        \n                          \u03c0\n                        \n                      \n                      ) for pancreatic cancer: a comparative planning study with IMPT","name":"article_title","label":"Article Title"},{"value":"Physics in Medicine & Biology","name":"journal_title","label":"Journal Title"},{"value":"paper","name":"article_type","label":"Article Type"},{"value":"\u00a9 2026 Institute of Physics and Engineering in Medicine. All rights, including for text and data mining, AI training, and similar technologies, are reserved.","name":"copyright_information","label":"Copyright Information"},{"value":"2026-06-30","name":"date_received","label":"Date Received","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2026-10-05","name":"date_accepted","label":"Date Accepted","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2026-10-22","name":"date_epub","label":"Online publication date","group":{"name":"publication_dates","label":"Publication dates"}}]}}